Medicine & Life Sciences
Breast Neoplasms
100%
N-(4-(3-chloro-4-(2-pyridinylmethoxy)anilino)-3-cyano-7-ethoxy-6-quinolyl)-4-(dimethylamino)-2-butenamide
84%
Mutation
60%
Trastuzumab
57%
Phosphotransferases
32%
Protein-Tyrosine Kinases
26%
Circulating Tumor DNA
25%
Neoplasms
23%
ErbB Receptors
23%
pertuzumab
23%
Ado-Trastuzumab Emtansine
21%
Genome
18%
zirconium-89-trastuzumab
17%
human ERBB2 protein
16%
Paclitaxel
16%
Therapeutics
15%
Ceramides
14%
Genes
14%
Estrogen Receptors
12%
Phosphorylation
12%
Capecitabine
12%
Lapatinib
11%
Fulvestrant
11%
Clinical Trials
11%
erbB-2 Genes
10%
Receptor Protein-Tyrosine Kinases
10%
Loperamide
10%
Diarrhea
10%
Proteins
10%
Randomized Controlled Trials
8%
Progression-Free Survival
8%
palbociclib
8%
DNA Sequence Analysis
7%
Proteomics
7%
Gene Amplification
7%
Confidence Intervals
7%
Tyrosine
7%
TEV protease
7%
Colorectal Neoplasms
7%
Phosphopeptides
6%
Phosphotyrosine
6%
Psychological Inhibition
6%
Dimerization
6%
dihydroceramide desaturase
6%
Squamous Cell Neoplasms
6%
Apoptosis
6%
Lobular Carcinoma
6%
CSK Tyrosine-Protein Kinase
6%
Drug Resistance
6%
Safety
6%